試す 金 - 無料
Rasna buys Jumpin from Hershey's
Mint Mumbai
|May 20, 2025
Instant beverage maker Rasna on Monday announced that it has acquired the brand Jumpin from Hershey's India for expanding into the ready-to-drink category.
-
Rasna didn't disclose the amount it paid for the 100% acquisition. However, it indicated independent agencies valued it at ₹350 crore.
このストーリーは、Mint Mumbai の May 20, 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Mint Mumbai からのその他のストーリー
Mint Mumbai
The cost of convenience for tap-to-book domestic help
Frequent change of helpers, surge pricing and slot shortages remain key pain points for users
3 mins
May 14, 2026
Mint Mumbai
Billboard has kept humans off its charts before: why not AI?
This tracker of musical hits must show how discerning it really is
3 mins
May 14, 2026
Mint Mumbai
Flex-fuel vehicle plan caught in dilemma
The government's push for flex-fuel vehicle rollout is facing a classic chicken-and-egg stalemate.
2 mins
May 14, 2026
Mint Mumbai
Hollywood retreats but Cannes thrives
Cannes has grown as a breeding ground for genuine Oscar contenders
2 mins
May 14, 2026
Mint Mumbai
Dixon’s stumble is a test for electronics manufacturers
Dixon Technologies’ consolidated revenues rose by just 2% year-on-year in the March quarter (Q4FY26) to ₹10,511 crore, the same as Q3’s growth rate.
1 mins
May 14, 2026
Mint Mumbai
The taste of summer in a platter of aamras-puri
Hand-pressed pulp of Hapus, Payri and Kesar mango varieties is being tinned, and turned into modern desserts
4 mins
May 14, 2026
Mint Mumbai
Cipla builds biosimilars pipeline as profit dips in 2025-26
Cipla is building a biosimilars pipeline, and aims to steadily add products over five years, its top executive said, as the company bets on the fast-growing market for cheaper versions of complex biologic drugs.
1 min
May 14, 2026
Mint Mumbai
Skyroot ties founder Esops to rocket launch milestones
The homegrown space-tech startup recently raised $60 million at a valuation of $1.1 billion
2 mins
May 14, 2026
Mint Mumbai
Zydus buys US cancer drug maker Assertio
Zydus Lifesciences said on Wednesday that it will acquire Nasdaq-listed pharmaceutical company Assertio Holdings for $166.4 million in an all-cash deal via its subsidiary. Assertio focuses on specialty and oncology supportive-care therapy.
1 min
May 14, 2026
Mint Mumbai
Air India slashes global flights as fuel costs, airspace curbs bite
Air India plans to operate around 37% fewer international flights between June and August compared with April, as prolonged airspace restrictions and soaring aviation fuel prices amid the West Asia war weigh on their viability.
1 mins
May 14, 2026
Listen
Translate
Change font size